Simply Managing Complex Data

Virology

S. Yerly , V. von Wyl , J. Böni , J. Schüpbach , P. Burgisser, T. Klimkait, M. Rickenbach, B. Ledergerber, H. Günthard, L. Perrin, and the Swiss HIV Cohort Study. Poster presented during the Forum for Collaborative HIV Research Standardization & Clinical Relevance of HIV Drug Resistance Working Group Meeting. Sitges, 2006. This email address is being protected from spambots. You need JavaScript enabled to view it.

TA Crowell, B. Danboise, A. Parikh, A. Esber, N. Dear, P. Coakley, A. Kasembeli, J. Maswai, S. Khamadi, E. Bahemana, M. Iroezindu, F. Kiweewa, J. Owuoth, J. Freeman, LL Jagodzinski, JA Malia, LA Eller, S. Tovanabutra, SA Peel, JA Ake, CS Polyak, AFRICOS Study Group. Clin Infect Dis, 2020 Aug 12; ciaa1161.doi: 10.1093/cid/ciaa1161. This email address is being protected from spambots. You need JavaScript enabled to view it.

C. Soulie, L. Assoumou, B. Abdi, S. Sayon, T. Nguyen, MA Valantin, L. Benigue, V. Ferre, C. Alloui, B. Montes, V. Avettand-Fenoel, C. Delaugerre, D. Descamps, E. Martinez, J. Reynes, G. Peytavin, D. Costagliola, C. Katlama, V. Calvez, and AG Marcelin on behalf of the ANRS-163 ETRAL study group. Journal of Antimicrobial Chemotherapy, 2020 Jul 1;75(7):1943-1949.doi: 10.1093/jac/dkaa090. This email address is being protected from spambots. You need JavaScript enabled to view it.

  1. Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy
  2. Routine drug resistance testing in HIV-1 proviral DNA, using an automated next- generation sequencing assay
  3. First evaluation of the Next-Generation Sequencing platform for the detection of HIV-1 drug resistance mutations in Belgium
  4. Characterization update of HIV-1 M subtypes diversity and proposal for subtypes A and D sub-subtypes reclassification